Tag: biomedical
-
Antibody Drug Biotech Raises $105M in Venture Funds
A company that says it has a faster process for discovering therapeutic antibodies is raising $105 million in its second venture finance round.
-
Labs Creating Mask Electronic Sterilization Process
Researchers from academic engineering and biology labs designed an electronic process for sterilizing N95 respirator face masks enabling their safe reuse.
-
Merck Inks Three Covid-19 Vaccine, Therapy Deals
Drug maker Merck today gained a new acquisition, along with collaboration and licensing deals, for vaccines and a therapy for Covid-19 infections.
-
Depression Therapy Licensed for Online Distribution
A therapy program for depression designed to reduce spirals of repeated negative thinking is licensed to a digital mental health company for online use.
-
Covid-19 Therapies Designed with Virtual Reality, A.I.
Two companies are using deep learning and virtual reality to design treatments for Covid-19 infections, attacking a different target than most drugs being developed.
-
GSK, Biotech Partner on Crispr Covid-19 Test
A biotechnology company using gene editing for diagnostics is developing a fast, point-of-care Covid-19 test with drug maker GlaxoSmithKline.
-
Covid-19 Vaccine Produces Antibodies in Preclinical Test
Tests with lab animals show a Covid-19 vaccine now in clinical trials produces neutralizing antibodies to prevent coronavirus infections.
-
Venture Producing Covid-19 Antibody Test Kits
A new company formed from a medical research lab is producing test kits for detecting and measuring a person’s Covid-19 antibodies.
-
FDA Analyzing Real-World Evidence on Covid-19
The Food and Drug Administration is analyzing collections of health records to gain more evidence-based insights into the course of the Covid-19 pandemic.
-
Antibody Neutralizes Covid-19, SARS Viruses
An academic-industry team discovered that an antibody produced during the 2003 SARS outbreak can neutralize similar viruses causing Covid-19 infections.